CYRUSONE INC. Lease, Cost
CYRUSONE INC. reported Lease, Cost of $26.20 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-02-17
- CYRUSONE INC. lease, cost for the quarter ending 2021-12-31 was $7.10M, a 10.94% increase year-over-year.
- CYRUSONE INC. lease, cost for the quarter ending 2021-09-30 was $6.50M, a 4.84% increase year-over-year.
- CYRUSONE INC. lease, cost for the quarter ending 2021-06-30 was $6.50M, a 13.33% decline year-over-year.
- CYRUSONE INC. lease, cost for the quarter ending 2021-03-31 was $6.10M, a 12.86% decline year-over-year.
- CYRUSONE INC. lease, cost for fiscal 2021 was $26.20M, a 9.17% increase from fiscal 2020.
- CYRUSONE INC. lease, cost for fiscal 2020 was $24.00M, a 1.23% decline from fiscal 2019.
- CYRUSONE INC. lease, cost for fiscal 2019 was $24.30M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $13.60M derived: sum of 2 quarters · filed 2022-02-17 | $20.10M derived: sum of 3 quarters · filed 2022-02-17 | $26.20M 10-K · filed 2022-02-17 |
| 2021-09-30 | $6.50M 10-Q · filed 2021-10-28 | $13.00M derived: sum of 2 quarters · filed 2021-10-28 | $19.10M 10-Q · filed 2021-10-28 | $25.50M derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-06-30 | $6.50M 10-Q · filed 2021-07-29 | $12.60M 10-Q · filed 2021-07-29 | $19.00M derived: sum of 3 quarters · filed 2022-02-17 | $25.20M derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-03-31 | $6.10M 10-Q · filed 2021-04-29 | $12.50M derived: sum of 2 quarters · filed 2022-02-17 | $18.70M derived: sum of 3 quarters · filed 2022-02-17 | $26.20M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $12.60M derived: sum of 2 quarters · filed 2022-02-17 | $20.10M derived: sum of 3 quarters · filed 2022-02-17 | $24.00M 10-K · filed 2022-02-17 |
| 2020-09-30 | $6.20M 10-Q · filed 2021-10-28 | $13.70M derived: sum of 2 quarters · filed 2021-10-28 | $17.60M 10-Q · filed 2021-10-28 | $27.60M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $7.50M 10-Q · filed 2021-07-29 | $14.50M 10-Q · filed 2021-07-29 | $21.40M derived: sum of 3 quarters · filed 2022-02-17 | $27.20M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $7.00M 10-Q · filed 2021-04-29 | $13.90M derived: sum of 2 quarters · filed 2022-02-17 | $19.70M derived: sum of 3 quarters · filed 2022-02-17 | $25.30M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $12.70M derived: sum of 2 quarters · filed 2022-02-17 | $18.30M derived: sum of 3 quarters · filed 2022-02-17 | $24.30M 10-K · filed 2022-02-17 |
| 2019-09-30 | $5.80M 10-Q · filed 2020-10-29 | $11.40M derived: sum of 2 quarters · filed 2020-10-29 | $17.40M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $5.60M 10-Q · filed 2020-07-31 | $11.60M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $6.10M 10-Q · filed 2020-04-30 |